Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Opioid-Related Disorders × Midazolam × 30 days × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Urothelial Cancer 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Opioid-Related Disorders 1 Neoplasms 1 Leiomyosarcoma 1 KRAS p.G12C Mutant Advanced Solid Tumors 1 Cancer Pain 1 Advanced Malignancies 1

Interventions

Tirzepatide 1 Standard of Care 1 Midazolam 1 Lidocaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07408193 2026-02-20

The Role of Coadministration of Lidocaine and Ketamine in Opioid-Refractory Chronic Cancer-Related Pain.

National and Kapodistrian University of Athens

Phase EARLY_PHASE1 Not yet recruiting

Cancer Pain, Opioid-Related Disorders, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡